CytomX Therapeutics
Price & Volume
Stats
See moreOpen | $0.58 |
Previous Close | $0.60 |
Day Range | $0.54-$0.58 |
52W Range | $0.56-$5.85 |
Market Cap | $46.4M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $138.1M |
Revenue Growth (YoY) | 43.2% |
Gross Profit (12 Mos) | $138.1M |
Diluted EPS | $0.38 |
News
See moreYahoo Finance • 29 days ago
CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update
Yahoo Finance • 30 days ago
CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference
Yahoo Finance • last year
CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Yahoo Finance • last year
CytomX Therapeutics to Present at Upcoming November Investor Conferences
About
CEO | Dr. Sean A. McCarthy DPHIL |
Address | 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 119 |
